Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the OPTIMA Study.
Saved in:
| Title: | Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the OPTIMA Study. |
|---|---|
| Authors: | Bouthillier A; Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, Canada., Bastien G; Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, Canada., McAnulty C; Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, Canada., Bakouni H; Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, Canada., Le Foll B; Translational Addiction Research Laboratory, Campbell Family Mental Health Research Institute, Center for Addiction and Mental Health, Toronto, ON, Canada.; Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; Department of Family and Community Medicine, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, ON, Canada., Socias ME; British Columbia Centre on Substance Use, Vancouver, BC, Canada.; Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Jutras-Aswad D; Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada. didier.jutras-aswad@umontreal.ca.; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, Canada. didier.jutras-aswad@umontreal.ca. |
| Source: | Harm reduction journal [Harm Reduct J] 2025 Feb 08; Vol. 22 (1), pp. 14. Date of Electronic Publication: 2025 Feb 08. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Pragmatic Clinical Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101153624 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7517 (Electronic) Linking ISSN: 14777517 NLM ISO Abbreviation: Harm Reduct J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1477-7517 |
|---|---|
| DOI: | 10.1186/s12954-025-01157-4 |
